Category: Asthma
Asthma market research reports by GlobalData
-
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Devel ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ... Read More
-
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. GlobalData's Medical Devices sector report, “Dry Powder Inhaler Devices Pipeline Report in ... Read More
-
Digital Marketing Trends in Asthma
Digital Marketing Trends in Asthma Summary Sanofi/Regeneron’s Dupixent.com achieved the highest total traffic across branded asthma patient sites in the US, with over 5.7 million visitors from June 2022 to May 2023. This was followed by GSK’s Trelegy.com (2.5 million visits) and Nucala.com (1.4 mill ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in COPD therapeutics. Synopsis There are more than 126 million diagnosed ... Read More
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Asthma therapeutics. Synopsis In 2022, there will be more than 260.6 million diagnosed prevalent cases of A ... Read More
-
Digital Marketing Trends in Severe Asthma
Digital Marketing Trends in Severe Asthma Summary Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022, with about 7,800,000 visits, followed by Novartis’ Xolair.com, and GSK’s Nucala.com. The highest proportion ... Read More
Research Assistance
